Patients who undergo both TAVI and complex/high-risk PCI see fewer adverse events and less procedural risk if their procedures are done using a staged rather than concomitant strategy, data from the ...
Medtronic announced it is supporting the investigator-initiated EMBRACE trial of the company’s Symplicity Spyral renal dene ...
After a failed percutaneous coronary intervention (PCI) for chronic total occlusion (CTO), subintimal tracking and reentry (STAR) with the definitive stenting staged at either 5-7 weeks or 12-14 weeks ...
Medtronic (NYSE:MDT) announced the launch of the EMBRACE trial of its Symplicity Spyral renal denervation (RDN) system.
TCT 1805: Successful Multivessel PCI for Severe LV Dysfunction and Anomalous RCA Origin With the Aid of a Novel 9F Expandable Ventricular Assist Device Receive the the latest news, research, and ...
The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results